Compositions and Methods for Treating Vascular Disorders
Background
Tulane is actively seeking commercial entities to further develop and commercialize our novel composition of viral vectors for impairment of pathological angiogenesis
Applications
Anti-angiogenic therapy for treatment of age-related macular degeneration, atherosclerosis, diabetic retinopathy, and cancer
Current Work
Proof-of-concept studies completed.
Inventors
Qinbo Zhou, PhD
Intellectual Property
Available For
Exclusive License in a Field
Non-exclusive License
Scientific Collaboration
